BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Pöhlmann S, Zhang J, Baribaud F, Chen Z, Leslie GJ, Lin G, Granelli-Piperno A, Doms RW, Rice CM, McKeating JA. Hepatitis C virus glycoproteins interact with DC-SIGN and DC-SIGNR. J Virol. 2003;77:4070-4080. [PMID: 12634366 DOI: 10.1128/jvi.77.7.4070-4080.2003] [Cited by in Crossref: 287] [Cited by in F6Publishing: 145] [Article Influence: 15.9] [Reference Citation Analysis]
Number Citing Articles
1 Hanna SL, Pierson TC, Sanchez MD, Ahmed AA, Murtadha MM, Doms RW. N-linked glycosylation of west nile virus envelope proteins influences particle assembly and infectivity. J Virol 2005;79:13262-74. [PMID: 16227249 DOI: 10.1128/JVI.79.21.13262-13274.2005] [Cited by in Crossref: 172] [Cited by in F6Publishing: 102] [Article Influence: 10.8] [Reference Citation Analysis]
2 Goffard A, Callens N, Bartosch B, Wychowski C, Cosset FL, Montpellier C, Dubuisson J. Role of N-linked glycans in the functions of hepatitis C virus envelope glycoproteins. J Virol. 2005;79:8400-8409. [PMID: 15956584 DOI: 10.1128/jvi.79.13.8400-8409.2005] [Cited by in Crossref: 187] [Cited by in F6Publishing: 123] [Article Influence: 11.7] [Reference Citation Analysis]
3 Navarro-Sanchez E, Altmeyer R, Amara A, Schwartz O, Fieschi F, Virelizier JL, Arenzana-Seisdedos F, Desprès P. Dendritic-cell-specific ICAM3-grabbing non-integrin is essential for the productive infection of human dendritic cells by mosquito-cell-derived dengue viruses. EMBO Rep. 2003;4:723-728. [PMID: 12783086 DOI: 10.1038/sj.embor.embor866] [Cited by in Crossref: 344] [Cited by in F6Publishing: 329] [Article Influence: 20.2] [Reference Citation Analysis]
4 Gramberg T, Zhu T, Chaipan C, Marzi A, Liu H, Wegele A, Andrus T, Hofmann H, Pöhlmann S. Impact of polymorphisms in the DC-SIGNR neck domain on the interaction with pathogens. Virology 2006;347:354-63. [PMID: 16413044 DOI: 10.1016/j.virol.2005.11.033] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 1.6] [Reference Citation Analysis]
5 Bozek K, Lengauer T. Positive selection of HIV host factors and the evolution of lentivirus genes. BMC Evol Biol 2010;10:186. [PMID: 20565842 DOI: 10.1186/1471-2148-10-186] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
6 Gerold G, Bruening J, Weigel B, Pietschmann T. Protein Interactions during the Flavivirus and Hepacivirus Life Cycle. Mol Cell Proteomics 2017;16:S75-91. [PMID: 28077444 DOI: 10.1074/mcp.R116.065649] [Cited by in Crossref: 34] [Cited by in F6Publishing: 19] [Article Influence: 8.5] [Reference Citation Analysis]
7 Ludwig IS, Lekkerkerker AN, Depla E, Bosman F, Musters RJ, Depraetere S, van Kooyk Y, Geijtenbeek TB. Hepatitis C virus targets DC-SIGN and L-SIGN to escape lysosomal degradation. J Virol. 2004;78:8322-8332. [PMID: 15254204 DOI: 10.1128/jvi.78.15.8322-8332.2004] [Cited by in Crossref: 101] [Cited by in F6Publishing: 49] [Article Influence: 5.9] [Reference Citation Analysis]
8 Feng ZH, Wang QC, Nie QH, Jia ZS, Zhou YX. DC-SIGN: binding receptor for HCV? World J Gastroenterol 2004;10:925-9. [PMID: 15052667 DOI: 10.3748/wjg.v10.i7.925] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
9 Owsianka AM, Timms JM, Tarr AW, Brown RJ, Hickling TP, Szwejk A, Bienkowska-Szewczyk K, Thomson BJ, Patel AH, Ball JK. Identification of conserved residues in the E2 envelope glycoprotein of the hepatitis C virus that are critical for CD81 binding. J Virol. 2006;80:8695-8704. [PMID: 16912317 DOI: 10.1128/jvi.00271-06] [Cited by in Crossref: 186] [Cited by in F6Publishing: 132] [Article Influence: 12.4] [Reference Citation Analysis]
10 Fuller GL, Williams JA, Tomlinson MG, Eble JA, Hanna SL, Pöhlmann S, Suzuki-Inoue K, Ozaki Y, Watson SP, Pearce AC. The C-type lectin receptors CLEC-2 and Dectin-1, but not DC-SIGN, signal via a novel YXXL-dependent signaling cascade. J Biol Chem 2007;282:12397-409. [PMID: 17339324 DOI: 10.1074/jbc.M609558200] [Cited by in Crossref: 168] [Cited by in F6Publishing: 89] [Article Influence: 12.0] [Reference Citation Analysis]
11 Ovsyannikova IG, Haralambieva IH, Crooke SN, Poland GA, Kennedy RB. The role of host genetics in the immune response to SARS-CoV-2 and COVID-19 susceptibility and severity. Immunol Rev 2020;296:205-19. [PMID: 32658335 DOI: 10.1111/imr.12897] [Cited by in Crossref: 57] [Cited by in F6Publishing: 41] [Article Influence: 57.0] [Reference Citation Analysis]
12 Ke PY, Chen SS. Autophagy in hepatitis C virus-host interactions: potential roles and therapeutic targets for liver-associated diseases. World J Gastroenterol 2014;20:5773-93. [PMID: 24914338 DOI: 10.3748/wjg.v20.i19.5773] [Cited by in CrossRef: 24] [Cited by in F6Publishing: 22] [Article Influence: 4.0] [Reference Citation Analysis]
13 Tabarani G, Thépaut M, Stroebel D, Ebel C, Vivès C, Vachette P, Durand D, Fieschi F. DC-SIGN neck domain is a pH-sensor controlling oligomerization: SAXS and hydrodynamic studies of extracellular domain. J Biol Chem 2009;284:21229-40. [PMID: 19502234 DOI: 10.1074/jbc.M109.021204] [Cited by in Crossref: 83] [Cited by in F6Publishing: 33] [Article Influence: 6.9] [Reference Citation Analysis]
14 Backovic M, Rey FA. Virus entry: old viruses, new receptors. Curr Opin Virol 2012;2:4-13. [PMID: 22440960 DOI: 10.1016/j.coviro.2011.12.005] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 1.9] [Reference Citation Analysis]
15 Counihan NA, Lindenbach BD. Gumming up the works: DNA polymers as HCV entry inhibitors. Gastroenterology 2009;137:427-30. [PMID: 19563837 DOI: 10.1053/j.gastro.2009.06.018] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
16 Liu Y, Liu J, Pang X, Liu T, Ning Z, Cheng G. The roles of direct recognition by animal lectins in antiviral immunity and viral pathogenesis. Molecules 2015;20:2272-95. [PMID: 25642837 DOI: 10.3390/molecules20022272] [Cited by in Crossref: 26] [Cited by in F6Publishing: 21] [Article Influence: 4.3] [Reference Citation Analysis]
17 Idris F, Muharram SH, Diah S. Glycosylation of dengue virus glycoproteins and their interactions with carbohydrate receptors: possible targets for antiviral therapy. Arch Virol 2016;161:1751-60. [PMID: 27068162 DOI: 10.1007/s00705-016-2855-2] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 3.6] [Reference Citation Analysis]
18 Cole G, Coleman N, Soilleux E. HCV and HIV binding lectin, DC-SIGNR, is expressed at all stages of HCV induced liver disease. J Clin Pathol 2004;57:79-80. [PMID: 14693842 DOI: 10.1136/jcp.57.1.79] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
19 Tomer S, Arora SK. A juggernaut of innate & adaptive immune cells in chronic hepatitis C. Indian J Med Res 2020;151:279-86. [PMID: 32461391 DOI: 10.4103/ijmr.IJMR_1387_17] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
20 Knolle PA, Wohlleber D. Immunological functions of liver sinusoidal endothelial cells. Cell Mol Immunol. 2016;13:347-353. [PMID: 27041636 DOI: 10.1038/cmi.2016.5] [Cited by in Crossref: 84] [Cited by in F6Publishing: 75] [Article Influence: 16.8] [Reference Citation Analysis]
21 Koutsoudakis G, Kaul A, Steinmann E, Kallis S, Lohmann V, Pietschmann T, Bartenschlager R. Characterization of the early steps of hepatitis C virus infection by using luciferase reporter viruses. J Virol. 2006;80:5308-5320. [PMID: 16699011 DOI: 10.1128/jvi.02460-05] [Cited by in Crossref: 309] [Cited by in F6Publishing: 197] [Article Influence: 22.1] [Reference Citation Analysis]
22 Steffen I, Liss NM, Schneider BS, Fair JN, Chiu CY, Simmons G. Characterization of the Bas-Congo virus glycoprotein and its function in pseudotyped viruses. J Virol 2013;87:9558-68. [PMID: 23785218 DOI: 10.1128/JVI.01183-13] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
23 Alen MM, Schols D. Dengue virus entry as target for antiviral therapy. J Trop Med 2012;2012:628475. [PMID: 22529868 DOI: 10.1155/2012/628475] [Cited by in Crossref: 32] [Cited by in F6Publishing: 27] [Article Influence: 3.6] [Reference Citation Analysis]
24 Li HC, Yang CH, Lo SY. Cellular factors involved in the hepatitis C virus life cycle. World J Gastroenterol 2021;27:4555-81. [PMID: 34366623 DOI: 10.3748/wjg.v27.i28.4555] [Reference Citation Analysis]
25 Gramberg T, Hofmann H, Möller P, Lalor PF, Marzi A, Geier M, Krumbiegel M, Winkler T, Kirchhoff F, Adams DH, Becker S, Münch J, Pöhlmann S. LSECtin interacts with filovirus glycoproteins and the spike protein of SARS coronavirus. Virology 2005;340:224-36. [PMID: 16051304 DOI: 10.1016/j.virol.2005.06.026] [Cited by in Crossref: 143] [Cited by in F6Publishing: 130] [Article Influence: 8.9] [Reference Citation Analysis]
26 Rothwangl KB, Rong L. Analysis of a conserved RGE/RGD motif in HCV E2 in mediating entry. Virol J 2009;6:12. [PMID: 19171049 DOI: 10.1186/1743-422X-6-12] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
27 Yu Q, Chow EM, McCaw SE, Hu N, Byrd D, Amet T, Hu S, Ostrowski MA, Gray-Owen SD. Association of Neisseria gonorrhoeae Opa(CEA) with dendritic cells suppresses their ability to elicit an HIV-1-specific T cell memory response. PLoS One 2013;8:e56705. [PMID: 23424672 DOI: 10.1371/journal.pone.0056705] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 1.9] [Reference Citation Analysis]
28 Serrano-Gómez D, Martínez-Nuñez RT, Sierra-Filardi E, Izquierdo N, Colmenares M, Pla J, Rivas L, Martinez-Picado J, Jimenez-Barbero J, Alonso-Lebrero JL, González S, Corbí AL. AM3 modulates dendritic cell pathogen recognition capabilities by targeting DC-SIGN. Antimicrob Agents Chemother 2007;51:2313-23. [PMID: 17452477 DOI: 10.1128/AAC.01289-06] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
29 Mason CP, Tarr AW. Human lectins and their roles in viral infections. Molecules 2015;20:2229-71. [PMID: 25642836 DOI: 10.3390/molecules20022229] [Cited by in Crossref: 53] [Cited by in F6Publishing: 52] [Article Influence: 8.8] [Reference Citation Analysis]
30 Zeisel MB, Barth H, Schuster C, Baumert TF. Hepatitis C virus entry: molecular mechanisms and targets for antiviral therapy. Front Biosci (Landmark Ed) 2009;14:3274-85. [PMID: 19273272 DOI: 10.2741/3450] [Cited by in Crossref: 30] [Cited by in F6Publishing: 28] [Article Influence: 2.5] [Reference Citation Analysis]
31 Villanueva RA, Rouillé Y, Dubuisson J. Interactions between virus proteins and host cell membranes during the viral life cycle. Int Rev Cytol 2005;245:171-244. [PMID: 16125548 DOI: 10.1016/S0074-7696(05)45006-8] [Cited by in Crossref: 23] [Cited by in F6Publishing: 13] [Article Influence: 1.5] [Reference Citation Analysis]
32 Wilkinson AL, Qurashi M, Shetty S. The Role of Sinusoidal Endothelial Cells in the Axis of Inflammation and Cancer Within the Liver. Front Physiol 2020;11:990. [PMID: 32982772 DOI: 10.3389/fphys.2020.00990] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 11.0] [Reference Citation Analysis]
33 Breiman A, Grandvaux N, Lin R, Ottone C, Akira S, Yoneyama M, Fujita T, Hiscott J, Meurs EF. Inhibition of RIG-I-dependent signaling to the interferon pathway during hepatitis C virus expression and restoration of signaling by IKKepsilon. J Virol. 2005;79:3969-3978. [PMID: 15767399 DOI: 10.1128/jvi.79.7.3969-3978.2005] [Cited by in Crossref: 134] [Cited by in F6Publishing: 57] [Article Influence: 8.4] [Reference Citation Analysis]
34 Dubuisson J. Hepatitis C virus proteins. World J Gastroenterol 2007;13:2406-15. [PMID: 17552023 DOI: 10.3748/wjg.v13.i17.2406] [Cited by in CrossRef: 91] [Cited by in F6Publishing: 86] [Article Influence: 6.5] [Reference Citation Analysis]
35 Xu YF, Liu WL, Dong JQ, Liu WS, Feng QS, Chen LZ, Zeng YX, Zeng MS, Jia WH. Sequencing of DC-SIGN promoter indicates an association between promoter variation and risk of nasopharyngeal carcinoma in cantonese. BMC Med Genet 2010;11:161. [PMID: 21067616 DOI: 10.1186/1471-2350-11-161] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.2] [Reference Citation Analysis]
36 Li HF, Huang CH, Ai LS, Chuang CK, Chen SS. Mutagenesis of the fusion peptide-like domain of hepatitis C virus E1 glycoprotein: involvement in cell fusion and virus entry. J Biomed Sci. 2009;16:89. [PMID: 19778418 DOI: 10.1186/1423-0127-16-89] [Cited by in Crossref: 33] [Cited by in F6Publishing: 31] [Article Influence: 2.8] [Reference Citation Analysis]
37 Bleau C, Filliol A, Samson M, Lamontagne L. Mouse Hepatitis Virus Infection Induces a Toll-Like Receptor 2-Dependent Activation of Inflammatory Functions in Liver Sinusoidal Endothelial Cells during Acute Hepatitis. J Virol. 2016;90:9096-9113. [PMID: 27489277 DOI: 10.1128/jvi.01069-16] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
38 Kapadia SB, Barth H, Baumert T, McKeating JA, Chisari FV. Initiation of hepatitis C virus infection is dependent on cholesterol and cooperativity between CD81 and scavenger receptor B type I. J Virol 2007;81:374-83. [PMID: 17050612 DOI: 10.1128/JVI.01134-06] [Cited by in Crossref: 187] [Cited by in F6Publishing: 124] [Article Influence: 12.5] [Reference Citation Analysis]
39 Sheridan I, Pybus OG, Holmes EC, Klenerman P. High-resolution phylogenetic analysis of hepatitis C virus adaptation and its relationship to disease progression. J Virol 2004;78:3447-54. [PMID: 15016867 DOI: 10.1128/jvi.78.7.3447-3454.2004] [Cited by in Crossref: 70] [Cited by in F6Publishing: 32] [Article Influence: 4.1] [Reference Citation Analysis]
40 Khoo US, Chan KY, Chan VS, Lin CL. DC-SIGN and L-SIGN: the SIGNs for infection. J Mol Med (Berl) 2008;86:861-74. [PMID: 18458800 DOI: 10.1007/s00109-008-0350-2] [Cited by in Crossref: 93] [Cited by in F6Publishing: 78] [Article Influence: 7.2] [Reference Citation Analysis]
41 Larsson M, Babcock E, Grakoui A, Shoukry N, Lauer G, Rice C, Walker C, Bhardwaj N. Lack of phenotypic and functional impairment in dendritic cells from chimpanzees chronically infected with hepatitis C virus. J Virol. 2004;78:6151-6161. [PMID: 15163708 DOI: 10.1128/jvi.78.12.6151-6161.2004] [Cited by in Crossref: 51] [Cited by in F6Publishing: 18] [Article Influence: 3.0] [Reference Citation Analysis]
42 Tsegaye TS, Pöhlmann S. The multiple facets of HIV attachment to dendritic cell lectins. Cell Microbiol 2010;12:1553-61. [PMID: 20854332 DOI: 10.1111/j.1462-5822.2010.01519.x] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 2.4] [Reference Citation Analysis]
43 Cheynet V, Ruggieri A, Oriol G, Blond JL, Boson B, Vachot L, Verrier B, Cosset FL, Mallet F. Synthesis, assembly, and processing of the Env ERVWE1/syncytin human endogenous retroviral envelope. J Virol 2005;79:5585-93. [PMID: 15827173 DOI: 10.1128/JVI.79.9.5585-5593.2005] [Cited by in Crossref: 62] [Cited by in F6Publishing: 28] [Article Influence: 3.9] [Reference Citation Analysis]
44 Bartosch B, Verney G, Dreux M, Donot P, Morice Y, Penin F, Pawlotsky JM, Lavillette D, Cosset FL. An interplay between hypervariable region 1 of the hepatitis C virus E2 glycoprotein, the scavenger receptor BI, and high-density lipoprotein promotes both enhancement of infection and protection against neutralizing antibodies. J Virol. 2005;79:8217-8229. [PMID: 15956567 DOI: 10.1128/jvi.79.13.8217-8229.2005] [Cited by in Crossref: 222] [Cited by in F6Publishing: 117] [Article Influence: 13.9] [Reference Citation Analysis]
45 Hsu M, Zhang J, Flint M, Logvinoff C, Cheng-Mayer C, Rice CM, McKeating JA. Hepatitis C virus glycoproteins mediate pH-dependent cell entry of pseudotyped retroviral particles. Proc Natl Acad Sci USA. 2003;100:7271-7276. [PMID: 12761383 DOI: 10.1073/pnas.0832180100] [Cited by in Crossref: 612] [Cited by in F6Publishing: 586] [Article Influence: 34.0] [Reference Citation Analysis]
46 Rothwangl KB, Manicassamy B, Uprichard SL, Rong L. Dissecting the role of putative CD81 binding regions of E2 in mediating HCV entry: putative CD81 binding region 1 is not involved in CD81 binding. Virol J 2008;5:46. [PMID: 18355410 DOI: 10.1186/1743-422X-5-46] [Cited by in Crossref: 48] [Cited by in F6Publishing: 33] [Article Influence: 3.7] [Reference Citation Analysis]
47 Cormier EG, Durso RJ, Tsamis F, Boussemart L, Manix C, Olson WC, Gardner JP, Dragic T. L-SIGN (CD209L) and DC-SIGN (CD209) mediate transinfection of liver cells by hepatitis C virus. Proc Natl Acad Sci USA. 2004;101:14067-14072. [PMID: 15371595 DOI: 10.1073/pnas.0405695101] [Cited by in Crossref: 152] [Cited by in F6Publishing: 136] [Article Influence: 8.9] [Reference Citation Analysis]
48 Ogden SC, Tang H. The missing pieces of the HCV entry puzzle. Future Virol 2015;10:415-28. [PMID: 25960762 DOI: 10.2217/FVL.15.12] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
49 Chan VS, Chan KY, Chen Y, Poon LL, Cheung AN, Zheng B, Chan KH, Mak W, Ngan HY, Xu X, Screaton G, Tam PK, Austyn JM, Chan LC, Yip SP, Peiris M, Khoo US, Lin CL. Homozygous L-SIGN (CLEC4M) plays a protective role in SARS coronavirus infection. Nat Genet 2006;38:38-46. [PMID: 16369534 DOI: 10.1038/ng1698] [Cited by in Crossref: 99] [Cited by in F6Publishing: 95] [Article Influence: 6.2] [Reference Citation Analysis]
50 Simmons G. Filovirus entry. Adv Exp Med Biol 2013;790:83-94. [PMID: 23884587 DOI: 10.1007/978-1-4614-7651-1_5] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
51 Yang ZS, Huang SW, Wang WH, Lin CY, Wang CF, Urbina AN, Thitithanyanont A, Tseng SP, Lu PL, Chen YH, Wang SF. Identification of Important N-Linked Glycosylation Sites in the Hemagglutinin Protein and Their Functional Impact on DC-SIGN Mediated Avian Influenza H5N1 Infection. Int J Mol Sci 2021;22:E743. [PMID: 33451024 DOI: 10.3390/ijms22020743] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
52 Cormier EG, Tsamis F, Kajumo F, Durso RJ, Gardner JP, Dragic T. CD81 is an entry coreceptor for hepatitis C virus. Proc Natl Acad Sci U S A 2004;101:7270-4. [PMID: 15123813 DOI: 10.1073/pnas.0402253101] [Cited by in Crossref: 207] [Cited by in F6Publishing: 202] [Article Influence: 12.2] [Reference Citation Analysis]
53 Kaur D, Arora C, Raghava GPS. A Hybrid Model for Predicting Pattern Recognition Receptors Using Evolutionary Information. Front Immunol 2020;11:71. [PMID: 32082326 DOI: 10.3389/fimmu.2020.00071] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
54 Jiang J, Cun W, Wu X, Shi Q, Tang H, Luo G. Hepatitis C virus attachment mediated by apolipoprotein E binding to cell surface heparan sulfate. J Virol 2012;86:7256-67. [PMID: 22532692 DOI: 10.1128/JVI.07222-11] [Cited by in Crossref: 122] [Cited by in F6Publishing: 80] [Article Influence: 13.6] [Reference Citation Analysis]
55 Snyder GA, Colonna M, Sun PD. The structure of DC-SIGNR with a portion of its repeat domain lends insights to modeling of the receptor tetramer. J Mol Biol 2005;347:979-89. [PMID: 15784257 DOI: 10.1016/j.jmb.2005.01.063] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 1.8] [Reference Citation Analysis]
56 Shih YP, Chen CY, Liu SJ, Chen KH, Lee YM, Chao YC, Chen YM. Identifying epitopes responsible for neutralizing antibody and DC-SIGN binding on the spike glycoprotein of the severe acute respiratory syndrome coronavirus. J Virol 2006;80:10315-24. [PMID: 17041212 DOI: 10.1128/JVI.01138-06] [Cited by in Crossref: 34] [Cited by in F6Publishing: 25] [Article Influence: 2.3] [Reference Citation Analysis]
57 Shi Q, Jiang J, Luo G. Syndecan-1 serves as the major receptor for attachment of hepatitis C virus to the surfaces of hepatocytes. J Virol 2013;87:6866-75. [PMID: 23576506 DOI: 10.1128/JVI.03475-12] [Cited by in Crossref: 86] [Cited by in F6Publishing: 59] [Article Influence: 10.8] [Reference Citation Analysis]
58 Cox D. Targeting SARS-CoV-2-Platelet Interactions in COVID-19 and Vaccine-Related Thrombosis. Front Pharmacol 2021;12:708665. [PMID: 34290613 DOI: 10.3389/fphar.2021.708665] [Reference Citation Analysis]
59 Martinez MG, Bialecki MA, Belouzard S, Cordo SM, Candurra NA, Whittaker GR. Utilization of human DC-SIGN and L-SIGN for entry and infection of host cells by the New World arenavirus, Junín virus. Biochem Biophys Res Commun 2013;441:612-7. [PMID: 24183720 DOI: 10.1016/j.bbrc.2013.10.106] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 2.5] [Reference Citation Analysis]
60 Lopez Robles MD, Pallier A, Huchet V, Le Texier L, Remy S, Braudeau C, Delbos L, Moreau A, Louvet C, Brosseau C, Royer PJ, Magnan A, Halary F, Josien R, Cuturi MC, Anegon I, Chiffoleau E. Cell-surface C-type lectin-like receptor CLEC-1 dampens dendritic cell activation and downstream Th17 responses. Blood Adv 2017;1:557-68. [PMID: 29296975 DOI: 10.1182/bloodadvances.2016002360] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
61 Op den Brouw ML, de Jong MA, Ludwig IS, van der Molen RG, Janssen HL, Geijtenbeek TB, Woltman AM. Branched oligosaccharide structures on HBV prevent interaction with both DC-SIGN and L-SIGN. J Viral Hepat. 2008;15:675-683. [PMID: 18482282 DOI: 10.1111/j.1365-2893.2008.00993.x] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 1.4] [Reference Citation Analysis]
62 Irshad M, Mankotia DS, Irshad K. An insight into the diagnosis and pathogenesis of hepatitis C virus infection. World J Gastroenterol. 2013;19:7896-7909. [PMID: 24307784 DOI: 10.3748/wjg.v19.i44.7896] [Cited by in CrossRef: 39] [Cited by in F6Publishing: 32] [Article Influence: 5.6] [Reference Citation Analysis]
63 Cocquerel L, Kuo CC, Dubuisson J, Levy S. CD81-dependent binding of hepatitis C virus E1E2 heterodimers. J Virol. 2003;77:10677-10683. [PMID: 12970454 DOI: 10.1128/jvi.77.19.10677-10683.2003] [Cited by in Crossref: 74] [Cited by in F6Publishing: 39] [Article Influence: 4.1] [Reference Citation Analysis]
64 Marzi A, Gramberg T, Simmons G, Möller P, Rennekamp AJ, Krumbiegel M, Geier M, Eisemann J, Turza N, Saunier B, Steinkasserer A, Becker S, Bates P, Hofmann H, Pöhlmann S. DC-SIGN and DC-SIGNR interact with the glycoprotein of Marburg virus and the S protein of severe acute respiratory syndrome coronavirus. J Virol 2004;78:12090-5. [PMID: 15479853 DOI: 10.1128/JVI.78.21.12090-12095.2004] [Cited by in Crossref: 256] [Cited by in F6Publishing: 172] [Article Influence: 15.1] [Reference Citation Analysis]
65 Van Hamme E, Desmarets L, Dewerchin HL, Nauwynck HJ. Intriguing interplay between feline infectious peritonitis virus and its receptors during entry in primary feline monocytes. Virus Res 2011;160:32-9. [PMID: 21600938 DOI: 10.1016/j.virusres.2011.04.031] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.7] [Reference Citation Analysis]
66 Nijmeijer BM, Koopsen J, Schinkel J, Prins M, Geijtenbeek TB. Sexually transmitted hepatitis C virus infections: current trends, and recent advances in understanding the spread in men who have sex with men. J Int AIDS Soc 2019;22 Suppl 6:e25348. [PMID: 31468692 DOI: 10.1002/jia2.25348] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 21.0] [Reference Citation Analysis]
67 Martin F, Roth DM, Jans DA, Pouton CW, Partridge LJ, Monk PN, Moseley GW. Tetraspanins in viral infections: a fundamental role in viral biology? J Virol 2005;79:10839-51. [PMID: 16103137 DOI: 10.1128/JVI.79.17.10839-10851.2005] [Cited by in Crossref: 72] [Cited by in F6Publishing: 41] [Article Influence: 4.5] [Reference Citation Analysis]
68 Zhao LJ, Wang W, Ren H, Qi ZT. Interaction of L-SIGN with hepatitis C virus envelope protein E2 up-regulates Raf-MEK-ERK pathway. Cell Biochem Biophys 2013;66:589-97. [PMID: 23292357 DOI: 10.1007/s12013-012-9505-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
69 Revie D, Braich RS, Bayles D, Chelyapov N, Khan R, Geer C, Reisman R, Kelley AS, Prichard JG, Salahuddin SZ. Transmission of human hepatitis C virus from patients in secondary cells for long term culture. Virol J. 2005;2:37. [PMID: 15840164 DOI: 10.1186/1743-422x-2-37] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
70 Ding Q, von Schaewen M, Ploss A. The impact of hepatitis C virus entry on viral tropism. Cell Host Microbe. 2014;16:562-568. [PMID: 25525789 DOI: 10.1016/j.chom.2014.10.009] [Cited by in Crossref: 52] [Cited by in F6Publishing: 42] [Article Influence: 7.4] [Reference Citation Analysis]
71 Zhang Y, El-Far M, Dupuy FP, Abdel-Hakeem MS, He Z, Procopio FA, Shi Y, Haddad EK, Ancuta P, Sekaly RP. HCV RNA Activates APCs via TLR7/TLR8 While Virus Selectively Stimulates Macrophages Without Inducing Antiviral Responses. Sci Rep. 2016;6:29447. [PMID: 27385120 DOI: 10.1038/srep29447] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 5.0] [Reference Citation Analysis]
72 Saito K, Ait-Goughoulte M, Truscott SM, Meyer K, Blazevic A, Abate G, Ray RB, Hoft DF, Ray R. Hepatitis C virus inhibits cell surface expression of HLA-DR, prevents dendritic cell maturation, and induces interleukin-10 production. J Virol. 2008;82:3320-3328. [PMID: 18216090 DOI: 10.1128/jvi.02547-07] [Cited by in Crossref: 61] [Cited by in F6Publishing: 41] [Article Influence: 4.7] [Reference Citation Analysis]
73 Keck ZY, Li TK, Xia J, Bartosch B, Cosset FL, Dubuisson J, Foung SK. Analysis of a highly flexible conformational immunogenic domain a in hepatitis C virus E2. J Virol 2005;79:13199-208. [PMID: 16227243 DOI: 10.1128/JVI.79.21.13199-13208.2005] [Cited by in Crossref: 78] [Cited by in F6Publishing: 55] [Article Influence: 4.9] [Reference Citation Analysis]
74 Liu X, Lv J, Fang Y, Zhou P, Lu Y, Pan L, Zhang Z, Ma J, Zhang Y, Wang Y. Expression and Immunogenicity of Two Recombinant Fusion Proteins Comprising Foot-and-Mouth Disease Virus Structural Protein VP1 and DC-SIGN-Binding Glycoproteins. Biomed Res Int 2017;2017:7658970. [PMID: 29119112 DOI: 10.1155/2017/7658970] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
75 Bitzegeio J, Bankwitz D, Hueging K, Haid S, Brohm C, Zeisel MB, Herrmann E, Iken M, Ott M, Baumert TF, Pietschmann T. Adaptation of hepatitis C virus to mouse CD81 permits infection of mouse cells in the absence of human entry factors. PLoS Pathog 2010;6:e1000978. [PMID: 20617177 DOI: 10.1371/journal.ppat.1000978] [Cited by in Crossref: 85] [Cited by in F6Publishing: 80] [Article Influence: 7.7] [Reference Citation Analysis]
76 Vannberg FO, Chapman SJ, Khor CC, Tosh K, Floyd S, Jackson-Sillah D, Crampin A, Sichali L, Bah B, Gustafson P, Aaby P, McAdam KP, Bah-Sow O, Lienhardt C, Sirugo G, Fine P, Hill AV. CD209 genetic polymorphism and tuberculosis disease. PLoS One 2008;3:e1388. [PMID: 18167547 DOI: 10.1371/journal.pone.0001388] [Cited by in Crossref: 81] [Cited by in F6Publishing: 68] [Article Influence: 6.2] [Reference Citation Analysis]
77 Grove J, Nielsen S, Zhong J, Bassendine MF, Drummer HE, Balfe P, McKeating JA. Identification of a residue in hepatitis C virus E2 glycoprotein that determines scavenger receptor BI and CD81 receptor dependency and sensitivity to neutralizing antibodies. J Virol 2008;82:12020-9. [PMID: 18829747 DOI: 10.1128/JVI.01569-08] [Cited by in Crossref: 129] [Cited by in F6Publishing: 76] [Article Influence: 9.9] [Reference Citation Analysis]
78 Grove J, Huby T, Stamataki Z, Vanwolleghem T, Meuleman P, Farquhar M, Schwarz A, Moreau M, Owen JS, Leroux-Roels G, Balfe P, McKeating JA. Scavenger receptor BI and BII expression levels modulate hepatitis C virus infectivity. J Virol 2007;81:3162-9. [PMID: 17215280 DOI: 10.1128/JVI.02356-06] [Cited by in Crossref: 115] [Cited by in F6Publishing: 68] [Article Influence: 8.2] [Reference Citation Analysis]
79 Barth H, Cerino R, Arcuri M, Hoffmann M, Schürmann P, Adah MI, Gissler B, Zhao X, Ghisetti V, Lavezzo B. Scavenger receptor class B type I and hepatitis C virus infection of primary tupaia hepatocytes. J Virol. 2005;79:5774-5785. [PMID: 15827192 DOI: 10.1128/JVI.79.9.5774-5785.2005] [Cited by in Crossref: 66] [Cited by in F6Publishing: 25] [Article Influence: 4.1] [Reference Citation Analysis]
80 Colpitts CC, Tsai PL, Zeisel MB. Hepatitis C Virus Entry: An Intriguingly Complex and Highly Regulated Process. Int J Mol Sci 2020;21:E2091. [PMID: 32197477 DOI: 10.3390/ijms21062091] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 11.0] [Reference Citation Analysis]
81 Cambi A, de Lange F, van Maarseveen NM, Nijhuis M, Joosten B, van Dijk EM, de Bakker BI, Fransen JA, Bovee-Geurts PH, van Leeuwen FN, Van Hulst NF, Figdor CG. Microdomains of the C-type lectin DC-SIGN are portals for virus entry into dendritic cells. J Cell Biol 2004;164:145-55. [PMID: 14709546 DOI: 10.1083/jcb.200306112] [Cited by in Crossref: 177] [Cited by in F6Publishing: 162] [Article Influence: 10.4] [Reference Citation Analysis]
82 Hensler HR, Tomaszewski MJ, Rappocciolo G, Rinaldo CR, Jenkins FJ. Human herpesvirus 8 glycoprotein B binds the entry receptor DC-SIGN. Virus Res 2014;190:97-103. [PMID: 25018023 DOI: 10.1016/j.virusres.2014.07.003] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 3.3] [Reference Citation Analysis]
83 Flint M, von Hahn T, Zhang J, Farquhar M, Jones CT, Balfe P, Rice CM, McKeating JA. Diverse CD81 proteins support hepatitis C virus infection. J Virol. 2006;80:11331-11342. [PMID: 16943299 DOI: 10.1128/jvi.00104-06] [Cited by in Crossref: 119] [Cited by in F6Publishing: 81] [Article Influence: 7.9] [Reference Citation Analysis]
84 Tomer S, Chawla YK, Duseja A, Arora SK. Dominating expression of negative regulatory factors downmodulates major histocompatibility complex Class-II expression on dendritic cells in chronic hepatitis C infection. World J Gastroenterol 2016;22:5173-82. [PMID: 27298560 DOI: 10.3748/wjg.v22.i22.5173] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
85 Sansonno D, Lauletta G, Montrone M, Tucci FA, Nisi L, Dammacco F. Virological analysis and phenotypic characterization of peripheral blood lymphocytes of hepatitis C virus-infected patients with and without mixed cryoglobulinaemia. Clin Exp Immunol 2006;143:288-96. [PMID: 16412053 DOI: 10.1111/j.1365-2249.2005.02987.x] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 1.7] [Reference Citation Analysis]
86 Chaipan C, Soilleux EJ, Simpson P, Hofmann H, Gramberg T, Marzi A, Geier M, Stewart EA, Eisemann J, Steinkasserer A, Suzuki-Inoue K, Fuller GL, Pearce AC, Watson SP, Hoxie JA, Baribaud F, Pöhlmann S. DC-SIGN and CLEC-2 mediate human immunodeficiency virus type 1 capture by platelets. J Virol 2006;80:8951-60. [PMID: 16940507 DOI: 10.1128/JVI.00136-06] [Cited by in Crossref: 169] [Cited by in F6Publishing: 81] [Article Influence: 11.3] [Reference Citation Analysis]
87 Gramberg T, Soilleux E, Fisch T, Lalor PF, Hofmann H, Wheeldon S, Cotterill A, Wegele A, Winkler T, Adams DH, Pöhlmann S. Interactions of LSECtin and DC-SIGN/DC-SIGNR with viral ligands: Differential pH dependence, internalization and virion binding. Virology 2008;373:189-201. [PMID: 18083206 DOI: 10.1016/j.virol.2007.11.001] [Cited by in Crossref: 51] [Cited by in F6Publishing: 45] [Article Influence: 3.9] [Reference Citation Analysis]
88 Majid AM, Ezelle H, Shah S, Barber GN. Evaluating replication-defective vesicular stomatitis virus as a vaccine vehicle. J Virol 2006;80:6993-7008. [PMID: 16809305 DOI: 10.1128/JVI.00365-06] [Cited by in Crossref: 28] [Cited by in F6Publishing: 17] [Article Influence: 1.9] [Reference Citation Analysis]
89 Kam YW, Okumura Y, Kido H, Ng LF, Bruzzone R, Altmeyer R. Cleavage of the SARS coronavirus spike glycoprotein by airway proteases enhances virus entry into human bronchial epithelial cells in vitro. PLoS One 2009;4:e7870. [PMID: 19924243 DOI: 10.1371/journal.pone.0007870] [Cited by in Crossref: 114] [Cited by in F6Publishing: 102] [Article Influence: 9.5] [Reference Citation Analysis]
90 Sehgal M, Khan ZK, Talal AH, Jain P. Dendritic Cells in HIV-1 and HCV Infection: Can They Help Win the Battle? Virology (Auckl) 2013;4:1-25. [PMID: 25512691 DOI: 10.4137/VRT.S11046] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 0.1] [Reference Citation Analysis]
91 Friedman SL. Mechanisms of hepatic fibrogenesis. Gastroenterology. 2008;134:1655-1669. [PMID: 18471545 DOI: 10.1053/j.gastro.2008.03.003] [Cited by in Crossref: 1758] [Cited by in F6Publishing: 1685] [Article Influence: 135.2] [Reference Citation Analysis]
92 Bhella D. The role of cellular adhesion molecules in virus attachment and entry. Philos Trans R Soc Lond B Biol Sci 2015;370:20140035. [PMID: 25533093 DOI: 10.1098/rstb.2014.0035] [Cited by in Crossref: 41] [Cited by in F6Publishing: 32] [Article Influence: 6.8] [Reference Citation Analysis]
93 Sabahi A, Uprichard SL, Wimley WC, Dash S, Garry RF. Unexpected structural features of the hepatitis C virus envelope protein 2 ectodomain. J Virol 2014;88:10280-8. [PMID: 24991010 DOI: 10.1128/JVI.00874-14] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 3.3] [Reference Citation Analysis]
94 Ezzikouri S, Rebbani K, Fakhir FZ, Alaoui R, Nadir S, Diepolder H, Thursz M, Khakoo SI, Benjelloun S. The allele 4 of neck region liver-lymph node-specific ICAM-3-grabbing integrin variant is associated with spontaneous clearance of hepatitis C virus and decrease of viral loads. Clin Microbiol Infect 2014;20:O325-32. [PMID: 24283933 DOI: 10.1111/1469-0691.12403] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
95 François KO, Balzarini J. Potential of carbohydrate-binding agents as therapeutics against enveloped viruses. Med Res Rev 2012;32:349-87. [PMID: 20577974 DOI: 10.1002/med.20216] [Cited by in Crossref: 51] [Cited by in F6Publishing: 49] [Article Influence: 4.6] [Reference Citation Analysis]
96 Op De Beeck A, Voisset C, Bartosch B, Ciczora Y, Cocquerel L, Keck Z, Foung S, Cosset FL, Dubuisson J. Characterization of functional hepatitis C virus envelope glycoproteins. J Virol. 2004;78:2994-3002. [PMID: 14990718 DOI: 10.1128/jvi.78.6.2994-3002.2004] [Cited by in Crossref: 163] [Cited by in F6Publishing: 95] [Article Influence: 9.6] [Reference Citation Analysis]
97 Rodrigue-Gervais IG, Jouan L, Beaulé G, Sauvé D, Bruneau J, Willems B, Sékaly RP, Lamarre D. Poly(I:C) and lipopolysaccharide innate sensing functions of circulating human myeloid dendritic cells are affected in vivo in hepatitis C virus-infected patients. J Virol 2007;81:5537-46. [PMID: 17376921 DOI: 10.1128/JVI.01741-06] [Cited by in Crossref: 32] [Cited by in F6Publishing: 15] [Article Influence: 2.3] [Reference Citation Analysis]
98 Zhu YZ, Qian XJ, Zhao P, Qi ZT. How hepatitis C virus invades hepatocytes: the mystery of viral entry. World J Gastroenterol. 2014;20:3457-3467. [PMID: 24707128 DOI: 10.3748/wjg.v20.i13.3457] [Cited by in CrossRef: 31] [Cited by in F6Publishing: 29] [Article Influence: 5.2] [Reference Citation Analysis]
99 Grove J, Marsh M. The cell biology of receptor-mediated virus entry. J Cell Biol 2011;195:1071-82. [PMID: 22123832 DOI: 10.1083/jcb.201108131] [Cited by in Crossref: 272] [Cited by in F6Publishing: 237] [Article Influence: 27.2] [Reference Citation Analysis]
100 Meghil MM, Cutler CW. Oral Microbes and Mucosal Dendritic Cells, "Spark and Flame" of Local and Distant Inflammatory Diseases. Int J Mol Sci 2020;21:E1643. [PMID: 32121251 DOI: 10.3390/ijms21051643] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 10.0] [Reference Citation Analysis]
101 Alen MM, De Burghgraeve T, Kaptein SJ, Balzarini J, Neyts J, Schols D. Broad antiviral activity of carbohydrate-binding agents against the four serotypes of dengue virus in monocyte-derived dendritic cells. PLoS One 2011;6:e21658. [PMID: 21738755 DOI: 10.1371/journal.pone.0021658] [Cited by in Crossref: 46] [Cited by in F6Publishing: 41] [Article Influence: 4.6] [Reference Citation Analysis]
102 Brazzoli M, Bianchi A, Filippini S, Weiner A, Zhu Q, Pizza M, Crotta S. CD81 is a central regulator of cellular events required for hepatitis C virus infection of human hepatocytes. J Virol. 2008;82:8316-8329. [PMID: 18579606 DOI: 10.1128/jvi.00665-08] [Cited by in Crossref: 138] [Cited by in F6Publishing: 88] [Article Influence: 10.6] [Reference Citation Analysis]
103 Ho SH, Martin F, Higginbottom A, Partridge LJ, Parthasarathy V, Moseley GW, Lopez P, Cheng-Mayer C, Monk PN. Recombinant extracellular domains of tetraspanin proteins are potent inhibitors of the infection of macrophages by human immunodeficiency virus type 1. J Virol 2006;80:6487-96. [PMID: 16775336 DOI: 10.1128/JVI.02539-05] [Cited by in Crossref: 50] [Cited by in F6Publishing: 34] [Article Influence: 3.3] [Reference Citation Analysis]
104 Freer G, Matteucci D, Finlay BB. Influence of Dendritic Cells on Viral Pathogenicity. PLoS Pathog 2009;5:e1000384. [DOI: 10.1371/journal.ppat.1000384] [Cited by in Crossref: 34] [Cited by in F6Publishing: 29] [Article Influence: 2.8] [Reference Citation Analysis]
105 Kalia M, Jameel S. Virus entry paradigms. Amino Acids 2011;41:1147-57. [PMID: 19826903 DOI: 10.1007/s00726-009-0363-3] [Cited by in Crossref: 38] [Cited by in F6Publishing: 33] [Article Influence: 3.2] [Reference Citation Analysis]
106 Sandmann L, Ploss A. Barriers of hepatitis C virus interspecies transmission. Virology 2013;435:70-80. [PMID: 23217617 DOI: 10.1016/j.virol.2012.09.044] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
107 Lozach PY, Burleigh L, Staropoli I, Amara A. The C type lectins DC-SIGN and L-SIGN: receptors for viral glycoproteins. Methods Mol Biol. 2007;379:51-68. [PMID: 17502670 DOI: 10.1007/978-1-59745-393-6_4] [Cited by in Crossref: 34] [Cited by in F6Publishing: 31] [Article Influence: 2.4] [Reference Citation Analysis]
108 Lambotin M, Raghuraman S, Stoll-Keller F, Baumert TF, Barth H. A look behind closed doors: interaction of persistent viruses with dendritic cells. Nat Rev Microbiol 2010;8:350-60. [PMID: 20372157 DOI: 10.1038/nrmicro2332] [Cited by in Crossref: 47] [Cited by in F6Publishing: 41] [Article Influence: 4.3] [Reference Citation Analysis]
109 Buonaguro L, Tornesello ML, Tagliamonte M, Gallo RC, Wang LX, Kamin-Lewis R, Abdelwahab S, Lewis GK, Buonaguro FM. Baculovirus-derived human immunodeficiency virus type 1 virus-like particles activate dendritic cells and induce ex vivo T-cell responses. J Virol 2006;80:9134-43. [PMID: 16940524 DOI: 10.1128/JVI.00050-06] [Cited by in Crossref: 95] [Cited by in F6Publishing: 57] [Article Influence: 6.3] [Reference Citation Analysis]
110 Sung PS, Hsieh SL. C-type lectins and extracellular vesicles in virus-induced NETosis. J Biomed Sci 2021;28:46. [PMID: 34116654 DOI: 10.1186/s12929-021-00741-7] [Reference Citation Analysis]
111 Naarding MA, Ludwig IS, Groot F, Berkhout B, Geijtenbeek TB, Pollakis G, Paxton WA. Lewis X component in human milk binds DC-SIGN and inhibits HIV-1 transfer to CD4+ T lymphocytes. J Clin Invest 2005;115:3256-64. [PMID: 16239964 DOI: 10.1172/JCI25105] [Cited by in Crossref: 133] [Cited by in F6Publishing: 57] [Article Influence: 8.3] [Reference Citation Analysis]
112 Callens N, Ciczora Y, Bartosch B, Vu-Dac N, Cosset FL, Pawlotsky JM, Penin F, Dubuisson J. Basic residues in hypervariable region 1 of hepatitis C virus envelope glycoprotein e2 contribute to virus entry. J Virol 2005;79:15331-41. [PMID: 16306604 DOI: 10.1128/JVI.79.24.15331-15341.2005] [Cited by in Crossref: 58] [Cited by in F6Publishing: 30] [Article Influence: 3.9] [Reference Citation Analysis]
113 Faure M, Rabourdin-Combe C. Innate immunity modulation in virus entry. Curr Opin Virol 2011;1:6-12. [PMID: 22440562 DOI: 10.1016/j.coviro.2011.05.013] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 2.6] [Reference Citation Analysis]
114 Ni Y, Li JM, Liu MK, Zhang TT, Wang DP, Zhou WH, Hu LZ, Lv WL. Pathological process of liver sinusoidal endothelial cells in liver diseases. World J Gastroenterol. 2017;23:7666-7677. [PMID: 29209108 DOI: 10.3748/wjg.v23.i43.7666] [Cited by in CrossRef: 31] [Cited by in F6Publishing: 28] [Article Influence: 10.3] [Reference Citation Analysis]
115 Keck ZY, Op De Beeck A, Hadlock KG, Xia J, Li TK, Dubuisson J, Foung SK. Hepatitis C virus E2 has three immunogenic domains containing conformational epitopes with distinct properties and biological functions. J Virol. 2004;78:9224-9232. [PMID: 15308717 DOI: 10.1128/jvi.78.17.9224-9232.2004] [Cited by in Crossref: 116] [Cited by in F6Publishing: 79] [Article Influence: 6.8] [Reference Citation Analysis]
116 Kaplan DE. Immunopathogenesis of Hepatitis C Virus Infection. Gastroenterol Clin North Am 2015;44:735-60. [PMID: 26600217 DOI: 10.1016/j.gtc.2015.07.004] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
117 Rathore A, Chatterjee A, Sivarama P, Yamamoto N, Dhole TN. Role of homozygous DC-SIGNR 5/5 tandem repeat polymorphism in HIV-1 exposed seronegative North Indian individuals. J Clin Immunol 2008;28:50-7. [PMID: 17876530 DOI: 10.1007/s10875-007-9131-x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 1.4] [Reference Citation Analysis]
118 Zhang Y, Buckles E, Whittaker GR. Expression of the C-type lectins DC-SIGN or L-SIGN alters host cell susceptibility for the avian coronavirus, infectious bronchitis virus. Vet Microbiol 2012;157:285-93. [PMID: 22340967 DOI: 10.1016/j.vetmic.2012.01.011] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 2.0] [Reference Citation Analysis]
119 da Silva RC, Segat L, Crovella S. Role of DC-SIGN and L-SIGN receptors in HIV-1 vertical transmission. Hum Immunol. 2011;72:305-311. [PMID: 21277928 DOI: 10.1016/j.humimm.2011.01.012] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 2.5] [Reference Citation Analysis]
120 Davis CW, Nguyen HY, Hanna SL, Sánchez MD, Doms RW, Pierson TC. West Nile virus discriminates between DC-SIGN and DC-SIGNR for cellular attachment and infection. J Virol. 2006;80:1290-1301. [PMID: 16415006 DOI: 10.1128/jvi.80.3.1290-1301.2006] [Cited by in Crossref: 228] [Cited by in F6Publishing: 159] [Article Influence: 15.2] [Reference Citation Analysis]
121 El-Awady AR, Arce RM, Cutler CW. Dendritic cells: microbial clearance via autophagy and potential immunobiological consequences for periodontal disease. Periodontol 2000 2015;69:160-80. [PMID: 26252408 DOI: 10.1111/prd.12096] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 3.5] [Reference Citation Analysis]
122 Pednekar L, Pandit H, Paudyal B, Kaur A, Al-Mozaini MA, Kouser L, Ghebrehiwet B, Mitchell DA, Madan T, Kishore U. Complement Protein C1q Interacts with DC-SIGN via Its Globular Domain and Thus May Interfere with HIV-1 Transmission. Front Immunol 2016;7:600. [PMID: 28066413 DOI: 10.3389/fimmu.2016.00600] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
123 Protzer U, Maini MK, Knolle PA. Living in the liver: hepatic infections. Nat Rev Immunol 2012;12:201-13. [PMID: 22362353 DOI: 10.1038/nri3169] [Cited by in Crossref: 322] [Cited by in F6Publishing: 298] [Article Influence: 35.8] [Reference Citation Analysis]
124 Klimstra WB, Nangle EM, Smith MS, Yurochko AD, Ryman KD. DC-SIGN and L-SIGN can act as attachment receptors for alphaviruses and distinguish between mosquito cell- and mammalian cell-derived viruses. J Virol 2003;77:12022-32. [PMID: 14581539 DOI: 10.1128/jvi.77.22.12022-12032.2003] [Cited by in Crossref: 156] [Cited by in F6Publishing: 101] [Article Influence: 8.7] [Reference Citation Analysis]
125 Lai WK, Sun PJ, Zhang J, Jennings A, Lalor PF, Hubscher S, McKeating JA, Adams DH. Expression of DC-SIGN and DC-SIGNR on human sinusoidal endothelium: a role for capturing hepatitis C virus particles. Am J Pathol 2006;169:200-8. [PMID: 16816373 DOI: 10.2353/ajpath.2006.051191] [Cited by in Crossref: 78] [Cited by in F6Publishing: 64] [Article Influence: 5.2] [Reference Citation Analysis]
126 Arrighi JF, Pion M, Wiznerowicz M, Geijtenbeek TB, Garcia E, Abraham S, Leuba F, Dutoit V, Ducrey-Rundquist O, van Kooyk Y. Lentivirus-mediated RNA interference of DC-SIGN expression inhibits human immunodeficiency virus transmission from dendritic cells to T cells. J Virol. 2004;78:10848-10855. [PMID: 15452205 DOI: 10.1128/JVI.78.20.10848-10855.2004] [Cited by in Crossref: 89] [Cited by in F6Publishing: 46] [Article Influence: 5.2] [Reference Citation Analysis]
127 Gardner JP, Durso RJ, Arrigale RR, Donovan GP, Maddon PJ, Dragic T, Olson WC. L-SIGN (CD 209L) is a liver-specific capture receptor for hepatitis C virus. Proc Natl Acad Sci USA. 2003;100:4498-4503. [PMID: 12676990 DOI: 10.1073/pnas.0831128100] [Cited by in Crossref: 217] [Cited by in F6Publishing: 191] [Article Influence: 12.1] [Reference Citation Analysis]
128 Hiroishi K, Eguchi J, Ishii S, Hiraide A, Sakaki M, Doi H, Omori R, Imawari M. Immune response of cytotoxic T lymphocytes and possibility of vaccine development for hepatitis C virus infection. J Biomed Biotechnol 2010;2010:263810. [PMID: 20508848 DOI: 10.1155/2010/263810] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
129 McKeating JA, Zhang LQ, Logvinoff C, Flint M, Zhang J, Yu J, Butera D, Ho DD, Dustin LB, Rice CM. Diverse hepatitis C virus glycoproteins mediate viral infection in a CD81-dependent manner. J Virol. 2004;78:8496-8505. [PMID: 15280458 DOI: 10.1128/jvi.78.16.8496-8505.2004] [Cited by in Crossref: 129] [Cited by in F6Publishing: 69] [Article Influence: 7.6] [Reference Citation Analysis]
130 Wang QC, Feng ZH, Zhou YX, Nie QH. Induction of hepatitis C virus-specific cytotoxic T and B cell responses by dendritic cells expressing a modified antigen targeting receptor. World J Gastroenterol 2005;11:557-60. [PMID: 15641145 DOI: 10.3748/wjg.v11.i4.557] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
131 Karakus U, Pohl MO, Stertz S. Breaking the Convention: Sialoglycan Variants, Coreceptors, and Alternative Receptors for Influenza A Virus Entry. J Virol 2020;94:e01357-19. [PMID: 31776280 DOI: 10.1128/JVI.01357-19] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 8.0] [Reference Citation Analysis]
132 Bogdanos DP, Gao B, Gershwin ME. Liver immunology. Compr Physiol. 2013;3:567-598. [PMID: 23720323 DOI: 10.1002/cphy.c120011] [Cited by in Crossref: 31] [Cited by in F6Publishing: 48] [Article Influence: 3.9] [Reference Citation Analysis]
133 Falkowska E, Kajumo F, Garcia E, Reinus J, Dragic T. Hepatitis C virus envelope glycoprotein E2 glycans modulate entry, CD81 binding, and neutralization. J Virol. 2007;81:8072-8079. [PMID: 17507469 DOI: 10.1128/jvi.00459-07] [Cited by in Crossref: 108] [Cited by in F6Publishing: 68] [Article Influence: 7.7] [Reference Citation Analysis]
134 Tay FP, Huang M, Wang L, Yamada Y, Liu DX. Characterization of cellular furin content as a potential factor determining the susceptibility of cultured human and animal cells to coronavirus infectious bronchitis virus infection. Virology 2012;433:421-30. [PMID: 22995191 DOI: 10.1016/j.virol.2012.08.037] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 2.9] [Reference Citation Analysis]
135 Kachko A, Loesgen S, Shahzad-Ul-Hussan S, Tan W, Zubkova I, Takeda K, Wells F, Rubin S, Bewley CA, Major ME. Inhibition of hepatitis C virus by the cyanobacterial protein Microcystis viridis lectin: mechanistic differences between the high-mannose specific lectins MVL, CV-N, and GNA. Mol Pharm 2013;10:4590-602. [PMID: 24152340 DOI: 10.1021/mp400399b] [Cited by in Crossref: 29] [Cited by in F6Publishing: 26] [Article Influence: 3.6] [Reference Citation Analysis]
136 Zhao LJ, Wang W, Ren H, Qi ZT. ERK signaling is triggered by hepatitis C virus E2 protein through DC-SIGN. Cell Stress Chaperones 2013;18:495-501. [PMID: 23378214 DOI: 10.1007/s12192-013-0405-3] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 2.3] [Reference Citation Analysis]
137 Zhang J, Randall G, Higginbottom A, Monk P, Rice CM, McKeating JA. CD81 is required for hepatitis C virus glycoprotein-mediated viral infection. J Virol 2004;78:1448-55. [PMID: 14722300 DOI: 10.1128/jvi.78.3.1448-1455.2004] [Cited by in Crossref: 265] [Cited by in F6Publishing: 154] [Article Influence: 15.6] [Reference Citation Analysis]
138 LeBlanc EV, Kim Y, Capicciotti CJ, Colpitts CC. Hepatitis C Virus Glycan-Dependent Interactions and the Potential for Novel Preventative Strategies. Pathogens 2021;10:685. [PMID: 34205894 DOI: 10.3390/pathogens10060685] [Reference Citation Analysis]
139 Hillaire ML, Nieuwkoop NJ, Boon AC, de Mutsert G, Vogelzang-van Trierum SE, Fouchier RA, Osterhaus AD, Rimmelzwaan GF. Binding of DC-SIGN to the hemagglutinin of influenza A viruses supports virus replication in DC-SIGN expressing cells. PLoS One 2013;8:e56164. [PMID: 23424649 DOI: 10.1371/journal.pone.0056164] [Cited by in Crossref: 30] [Cited by in F6Publishing: 28] [Article Influence: 3.8] [Reference Citation Analysis]
140 Haid S, Windisch MP, Bartenschlager R, Pietschmann T. Mouse-specific residues of claudin-1 limit hepatitis C virus genotype 2a infection in a human hepatocyte cell line. J Virol 2010;84:964-75. [PMID: 19889758 DOI: 10.1128/JVI.01504-09] [Cited by in Crossref: 44] [Cited by in F6Publishing: 30] [Article Influence: 3.7] [Reference Citation Analysis]
141 Jeffers SA, Tusell SM, Gillim-Ross L, Hemmila EM, Achenbach JE, Babcock GJ, Thomas WD, Thackray LB, Young MD, Mason RJ. CD209L (L-SIGN) is a receptor for severe acute respiratory syndrome coronavirus. Proc Natl Acad Sci USA. 2004;101:15748-15753. [PMID: 15496474 DOI: 10.1073/pnas.0403812101] [Cited by in Crossref: 407] [Cited by in F6Publishing: 351] [Article Influence: 23.9] [Reference Citation Analysis]
142 Miao Z, Xie Z, Miao J, Ran J, Feng Y, Xia X. Regulated Entry of Hepatitis C Virus into Hepatocytes. Viruses 2017;9:E100. [PMID: 28486435 DOI: 10.3390/v9050100] [Cited by in Crossref: 29] [Cited by in F6Publishing: 25] [Article Influence: 7.3] [Reference Citation Analysis]
143 Sachdeva M, Chawla YK, Arora SK. Dendritic cells: The warriors upfront-turned defunct in chronic hepatitis C infection. World J Hepatol 2015;7:2202-8. [PMID: 26380045 DOI: 10.4254/wjh.v7.i19.2202] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
144 Simone O, Tortorella C, Zaccaro B, Napoli N, Antonaci S. Impairment of TLR7-dependent signaling in dendritic cells from chronic hepatitis C virus (HCV)-infected non-responders to interferon/ribavirin therapy. J Clin Immunol. 2010;30:556-565. [PMID: 20390327 DOI: 10.1007/s10875-010-9387-4] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.0] [Reference Citation Analysis]
145 Thomson AW, Knolle PA. Antigen-presenting cell function in the tolerogenic liver environment. Nat Rev Immunol. 2010;10:753-766. [PMID: 20972472 DOI: 10.1038/nri2858] [Cited by in Crossref: 466] [Cited by in F6Publishing: 402] [Article Influence: 42.4] [Reference Citation Analysis]